GSK′962，25MG，SML2377-25MG，Sigma

Biochem/physiol Actions

GSK′962 (GSK′962A) corresponds to the inactive (R)-enantiomer of the highly potent and selective RIPK1 (RIP1) inhibitor GSK′963 (GSK′963A). GSK′962 serves as an ideal GSK′963 negative control compound for probing RIPK1-mediated responses both in vitro and in vivo.
Inactive (R)-enantiomer and an ideal negative control of GSK′963 for probing RIPK1-mediated responses both in vitro and in vivo.